Spatial biology heralds a transformative shift in biomedicine. Clinicians may diagnose cancers by examining a tumor’s spatial architecture alongside genetics, while therapies could reprogram diseased microenvironments instead of solely targeting cells. From unraveling brain networks to building synthetic tissues, this spatial lens deciphers life’s deepest complexities.

Research-grade in vivo biosimilar antibodies provide a critical tool for scientists studying therapeutic mechanisms in disease models. Their high demand is fueled by the rapid growth of biopharmaceutical research, the need for cost-effective alternatives to commercial antibodies, and the expansion of immuno-oncology, neuroscience, and autoimmune disease research. 

Exosomes hold significant promise for diagnosing a broad range of diseases, highlighting their versatility as diagnostic tools. As research progresses, several distinct advantages of exosomes over traditional diagnostic methods become evident.